Approaches to the treatment of hepatitis B virus and delta-related liver disease.
D000328:Adult; D000818:Animals; D002353:Carrier State / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology / Q000628:therapy*; D006510:Hepatitis B Antibodies / Q000276:immunology; D003699:Hepatitis D / Q000276:immunology / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000276:immunology / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons / Q000276:immunology; D008297:Male; D002679:Pan troglodytes; D011241:Prednisone / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000627:therapeutic use
D006510:Hepatitis B Antibodies; D007370:Interferon Type I; D001084:Vidarabine Phosphate; D007371:Interferon-gamma; D007372:Interferons; D014740:Vidarabine; D011241:Prednisone